Louise Wang Zhiying Humphrey

Array ( [id] => 415382 [patent_doc_number] => 07279566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Centrosome proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/663433 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 96 [patent_no_of_words] => 26027 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279566.pdf [firstpage_image] =>[orig_patent_app_number] => 10663433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432309 [patent_doc_number] => 20040162254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Antiviral oligonucleotides targeting HSV and CMV' [patent_app_type] => new [patent_app_number] => 10/661097 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 35259 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162254.pdf [firstpage_image] =>[orig_patent_app_number] => 10661097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694736 [patent_doc_number] => 20060154883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Nonsense-mediated mrna decay' [patent_app_type] => utility [patent_app_number] => 10/525273 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 51595 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154883.pdf [firstpage_image] =>[orig_patent_app_number] => 10525273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256224 [patent_doc_number] => 20050143331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Antisense modulation of phospholipase A2, group IIA (synovial) expression' [patent_app_type] => utility [patent_app_number] => 10/643038 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26695 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143331.pdf [firstpage_image] =>[orig_patent_app_number] => 10643038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 243181 [patent_doc_number] => 07588915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-15 [patent_title] => 'Isolated genomic polynucleotide fragments from chromosome 7' [patent_app_type] => utility [patent_app_number] => 10/642946 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12822 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/588/07588915.pdf [firstpage_image] =>[orig_patent_app_number] => 10642946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199703 [patent_doc_number] => 20070299021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Modified Tailed Oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/524724 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20471 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299021.pdf [firstpage_image] =>[orig_patent_app_number] => 10524724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515536 [patent_doc_number] => 08039608 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-10-18 [patent_title] => 'Bioinformatically detectable group of novel regulatory genes and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/604726 [patent_app_country] => US [patent_app_date] => 2003-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 37 [patent_no_of_words] => 9619 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039608.pdf [firstpage_image] =>[orig_patent_app_number] => 10604726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7170367 [patent_doc_number] => 20040077834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Nucleic acid molecules encoding DRT111 and uses thereof' [patent_app_type] => new [patent_app_number] => 10/639037 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28038 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077834.pdf [firstpage_image] =>[orig_patent_app_number] => 10639037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117191 [patent_doc_number] => 20050070492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Treating cancer using antisense oligonucleotides against telomerase reverse transcriptase' [patent_app_type] => utility [patent_app_number] => 10/637443 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7668 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070492.pdf [firstpage_image] =>[orig_patent_app_number] => 10637443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397587 [patent_doc_number] => 20040038925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Inhibition of complement activation and complement modulation by use of modified oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/636452 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20427 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038925.pdf [firstpage_image] =>[orig_patent_app_number] => 10636452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 397744 [patent_doc_number] => 07294713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-13 [patent_title] => 'Antisense IAP oligonucleotides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/636065 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 33 [patent_no_of_words] => 16942 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/294/07294713.pdf [firstpage_image] =>[orig_patent_app_number] => 10636065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926472 [patent_doc_number] => 20050239728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Double stranded rna structures and constructs, and methods for generating and using the same' [patent_app_type] => utility [patent_app_number] => 10/522962 [patent_app_country] => US [patent_app_date] => 2003-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 50437 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239728.pdf [firstpage_image] =>[orig_patent_app_number] => 10522962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7400077 [patent_doc_number] => 20040023386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Modulation of nitric oxide synthase by PKC' [patent_app_type] => new [patent_app_number] => 10/629928 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15077 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023386.pdf [firstpage_image] =>[orig_patent_app_number] => 10629928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7352595 [patent_doc_number] => 20040048378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Modulation of homologous recombination with single stranded dna binding proteins' [patent_app_type] => new [patent_app_number] => 10/380688 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5741 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048378.pdf [firstpage_image] =>[orig_patent_app_number] => 10380688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7318967 [patent_doc_number] => 20040224913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Antisense oligomers' [patent_app_type] => new [patent_app_number] => 10/624447 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12928 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224913.pdf [firstpage_image] =>[orig_patent_app_number] => 10624447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7449892 [patent_doc_number] => 20040067588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Cell-free assay and in vivo method for plant genetic repair using chloroplast lysate' [patent_app_type] => new [patent_app_number] => 10/250632 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6744 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067588.pdf [firstpage_image] =>[orig_patent_app_number] => 10250632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7358578 [patent_doc_number] => 20040014122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Detection of spore forming bacteria' [patent_app_type] => new [patent_app_number] => 10/608062 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8335 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014122.pdf [firstpage_image] =>[orig_patent_app_number] => 10608062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434403 [patent_doc_number] => 20040266706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Cross-linked oligomeric compounds and their use in gene modulation' [patent_app_type] => new [patent_app_number] => 10/606510 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33537 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266706.pdf [firstpage_image] =>[orig_patent_app_number] => 10606510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7402377 [patent_doc_number] => 20040175375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Method for treating cancer using p38/JTV-1 and method for screening pharmaceutical composition for treating cancer' [patent_app_type] => new [patent_app_number] => 10/463676 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11473 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175375.pdf [firstpage_image] =>[orig_patent_app_number] => 10463676 [rel_patent_id] =>[rel_patent_doc_number] =>)